Biosynex completes acquisition of chembio diagnostics, inc.

Chembio diagnostics, inc. becomes the first north american structure  controlled by biosynex in north america strasbourg, france, april 27, 2023 (globe newswire) -- biosynex sa (“biosynex”) (epa: albio), a french market leader specializing in the design and distribution of rapid tests, today announced it has completed its acquisition of chembio diagnostics, inc. (“chembio”), a leading point-of-care diagnostics company focused on infectious diseases. chembio is now part of biosynex group.
CEMI Ratings Summary
CEMI Quant Ranking